CCR7 has emerged as an important marker in the prediction of axillary lymph node metastasis in breast carcinomas, particularly since CCR7 over-expression correlates with larger primary tumours, deeper lymphatic invasion and poorer survival rates [2]. This evidence concerns the gene CCR7 and breast carcinoma.